Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis

Neurology

Volumn 62, Issue 10, 2004, Pages 1894-1896

  Takamori, Masaharu ^a   Motomura, M ^b   Kawaguchi, N ^c   Nemoto, Y ^c   Hattori, T ^c   Yoshikawa, H ^d   Otsuka, K ^a  

^a Kanazawa Nishi Hospital   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR ANTIBODY; RYANODINE RECEPTOR; RYANODINE RECEPTOR ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY PRODUCING CELL; ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; FEMALE; GENE SEQUENCE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; ION CONDUCTANCE; MALE; MYASTHENIA GRAVIS; OPEN STUDY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SERODIAGNOSIS; THYMOMA;

EID: 2442636414     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000125254.99397.68     Document Type: Article

References (10)

1. Takamori M. Immunology of ryanodine receptor and FK506 in myasthenia gravis. In: Giralt E, Hirschmann RF, Jung G, et al., eds. Current topics in peptide & protein research. Vol. 5. Trivandrum: Research Trends, 2003;187-199.
2. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1990;265: 2244-2256.
3. Bhat MB, Zhao J, Takeshima H, Ma J. Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys J 1997;73:1329-1336.
4. Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 1987;139:1797-1803.
5. Timerman AP, Ogunbumni E, Freund E, Wiederrecht G, Marks AR, Fleischer S. The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstruction of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. J Biol Chem 1993;268:22992-22999.
6. Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology 1999;52: 1487-1489.
7. Skeie GO, Mygland Å, Treves S, Gilhus NE, Aarli JA, Zorzato F. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle Nerve 2003;27:81-89.
8. Kusner LL, Mygland Å, Kaminski HJ. Ryanodine receptor gene expression thymomas. Muscle Nerve 1998;21:1299-1303.
9. Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 2002;128:82-89.
10. Konishi T, Yoshiyama Y, Takamori M, et al. Clinical study of FK506 in patients with myasthenia gravis. Muscle Nerve 2003;28:570-574.